The Joint Corp.

JYNT Healthcare Medical Care Facilities

In the quarter to June 2026, revenue grew 14.4%, EPS grew 400.0% and free cash flow grew 432.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

7.03 0.12 +1.74%
Market cap
$97.7M
P/E
26.0×
Fwd P/E
16.9×
Dividend yield
—
F-score
7/9
Altman Z
2.39
Beneish M
−2.27
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
9 8 7 —

+8 more TTM periods

ROE
19.41% 16.90% 16.26% 8.95%
ROA
6.09% 4.69% 4.03% 2.60%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
16.77% 14.42% 12.96% 6.34%
Average Days of Receivables
15.01 15.10 18.95 19.45
Free Cash Flow per Share
0.30 0.19 0.02 0.11
Free Cash Flow
4.23 2.66 0.33 1.63
Capital Expenditures
(1.16) (1.41) (1.50) (1.44)
Other line items
Cash ROIC
10.88% 7.19% 0.85% 3.06%
Accounts Receivable Turnover
22.53 21.32 20.20 15.13
Accounts Payable Turnover
7.97 11.07 6.72 7.46
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
37.52 31.97 51.66 37.95
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.02) (0.03) 0.17 0.06
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
76.05% 76.47% 78.21% 77.27%
Share Based Compensation of Revenue
2.35% 2.27% 2.36% 2.16%
Operating CF/Net income
1.42 1.25 0.63 1.59
Depreciation/Fixed assets
0.61 0.57 0.54 0.60
Capex/Depreciation
(0.67) (0.81) (0.88) (0.79)
Revenue per Share
4.11 3.99 3.63 3.55
Operating CF per Share
0.38 0.29 0.12 0.20
Capex per Share
(0.08) (0.10) (0.10) (0.09)
Capex to Sales
0.02 0.02 0.03 0.03

Fold the line items

Columns are period end dates